A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer.
| Image |  |
|---|---|
| Description | scientific article published on 25 July 2012 |
| Author/s |
author: Young Whang |
| Publication date | July 25, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |